Abstract
It is generally approved that there is a further need for more selective and less toxic antiepileptic drugs (Krall et al. 1978 a, b). In the search for optimal designs for new drugs, medicinal chemists and pharmacologists would benefit from consideration of the rules which emerge from comparison of the structures of active and inactive compounds. It is therefore the aim of this chapter to give an impression of structure-activity relationships mainly of those classes of compounds which include well-known antiepileptic drugs. In general the specification of anticonvulsant activity will be restricted to data from electroshock and pentylenetetrazol-induced shock tests.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Aboul-Enein HY, Schauberger ChW, Hansen AR, Fischer LJ (1975) Synthesis of an active hydroxylated glutethimide metabolite and some related analogs with sedative-hypnotic and anticonvulsant properties. J Med Chem 18: 736–741
Amato RJ, Jones GL (1982) Reassessment of the anticonvulsant activity of diphenylacetyl urea. Drug Dev Res 2: 47–53
Andrews PR, Jones GP (1981) Convulsant and anticonvulsant barbiturates. 2. Molecular orbital calculations. Eur J Med Chem 16: 139–143
Andrews PR, Jones GP, Lodge D (1979) Convulsant, anticonvulsant and anaesthetic barbiturates. 5-Ethyl-5-(3′-methyl-but-2′-enyl)-barbituric acid and related compounds. Eur J Pharmacol 55: 115–120
Andrews PR, Jones A J, Jones GP, Marker A, Owen EA (1981) Convulsant and anticonvulsant barbiturates. 3. Conformational analysis by and 13C NMR. Eur J Med Chem 16: 145–150
Andrews PR, Jones GP, Poulton DB (1982) Convulsant, anticonvulsant and anaesthetic barbiturates. In vivo activities of oxo- and thiobarbiturates related to pentobarbitone. Eur J Pharmacol 79: 61–65
Astoin J, Marivain A, Riveron A, Crucifix M, Lapotre M, Torrens Y (1978) Action de nouveaux alcools - ethyleniques sur le systeme nerveux central. Eur J Med Chem 13: 41–47
Balsamo A, Barili PL, Crotti P, Macchia B, Macchia F, Pecchia A, Cuttica A, Passerini N (1975) Structure-activity relationships in cinnamamides. 1. Synthesis and pharmacological evaluation of some (E)- and (Z)-N-alkyl-α, β,Mimethylcinnamamides. J Med Chem 18: 842–846
Balsamo A, Barili PL, Crotti P, Macchia B, Macchia F, Cuttica A, Passerini N (1977) Structure-activity relationships in cinnamamides. 2. Synthesis and pharmacological evaluation of some (E)- and (Z)-N-alkyl- α, β,dimethylcinnamamides substituted on the phenyl group. J Med Chem 20: 48–53
Balsamo A, Crotti P, Lapucci A, Macchia B, Macchia F, Cuttica A, Passerini N (1981) Structure-activity relationship in cinnamamides. 3. Synthesis and anticonvulsant activity evaluation of some derivatives of (E)- and (Z)-m-(trifluoromethyl)cinnamamide. J Med Chem 24: 525–532
Baltzer V, Schmutz M (1977) Experimental anticonvulsive properties of GP 47680 and of GP 47 779, its main human metabolite; compounds related to carbamazepine. In: Meinardi H, Rowan AJ (eds) Advances in epileptology. Proceedings of the 13th congress of the international league against epilepsy and 9th symposium of the international bureau for epilepsy. Swets and Zeitlinger, Amsterdam, p 295
Barzaghi F, Fournex R, Mantegazza P (1973) Pharmacological and toxicological properties of clobazam (l-phenyl-5-methyl-8-chloro-1,2,4,5-tetrahydro-2,4-diketo-3i7-1,5- benzodiazepine), a new psychotherapeutic agent. Arzneimittelforsch 23: 683–686
Benoit-Guyod JL, Boucherle A, Benoit-Guyod M, Dardas A, Rupp R, Eymard P, Carraz G, Boitard M, Lebreton S, Beriel H, Meunier H (1968) Derives de l’acide dipropylacetique. III.Nouveaux amides et esters. Chim Ther 5: 336–342
Benoit-Guyod JL, Benoit-Guyod M, Boucherle A, Eymard P, Carraz G, Meunier H (1969) Derives de l’acide dipropylacetique. IV. Etude des relations entre la structure et l’activite antalgique de quelques dipropylacetanilides substitues. Chim Ther 1: 17–20
Benoit-Guyod M, Benoit-Guyod JL, Boucherle A, Broil M, Eymard P (1972) Recherches dans la serie dipropylacetique. VII. Structures homologues: amides et urees substitutes provenant de la propyl-1 butylamine. Eur J Med Chem 5: 388–392
Benoit-Guyod M, Benoit-Guyod JL, Boucherle A, Broil M, Eymard P (1973) Recherches dans la serie dipropylacetique. IX. Structures homologues: methyl-1 propyl-2 pentyl- amine, amides et urees substitutes. Eur J Med Chem 4: 412–418
Billman JH, Hidy PhH (1943) TV,TV-Substituted a-aminodiphenylacetamides. J Am Chem Soc 65: 760–761
Bogue JY, Carrington HC (1953) The evaluation of “Mysoline” - a new anticonvulsant drug. Br J Pharmacol 8: 230–236
Brown WC, Schiffman DO, Swinyard EA, Goodman LS (1953) Comparative assay of antiepileptic drugs by “psychomotor” seizure test and minimal electroshock threshold test. J Pharmacol Exp Ther 107: 273–283
Butler TC (1953) Quantitative studies of the demethylation of trimethadione (TRIDIONE®). J Pharmacol Exp Ther 108: 11–17
Butler TC, Waddell WJ (1957) Metabolic deethylation of 5,5-dimethyl-3-ethyl-2,4-oxazo- lidinedione (dimedion). Arch Int Pharmacodyn 111: 308–313
Caccia S, Carli M, Garattini S, Poggesi E, Rech R, Samanin R (1980 a) Pharmacological activities of clobazam and diazepam in the rat: relation to drug brain levels. Arch Int Pharmacodyn Ther 243: 275–283
Caccia S, Guiso G, Garattini S (1980 b) Brain concentrations of clobazam and N-desmeth- ylclobazam and antileptazol activity. J Pharm Pharmacol 32: 295–296
Caccia S, Ballabio M, Garattini S ( 1980 c) Relationship between camazepam, N-methyl- oxazepam and oxazepam brain concentrations and antileptazol effect in the rat. J Pharm Pharmacol 33: 185–187
Call L (1970) 5,5-Diphenyl-3-hydroxy-hydantoin. Monatsschr Chem 101:228–239
Camerman A, Camerman N (1980) Structure-activity relationships. Stereochemical similarities in chemically different antiepileptic drugs. In: Glaser GH, Penry JK, Woodbury DM (eds) Antiepileptic drugs: mechanism of action. Raven, New York, p 223
Carraz G (1967) Approches pour une theorie sur l’activite de la structure die -w-propyla-cetique. Agressologie 8: 13–20
Chen G, Bass P (1964) Certain pharmacological properties of 3-ethyl-2-methyl-2-phenyl- succinimide. Arch Int Pharmacodyn Ther 152: 115–120
Chen G, Portman R, Ensor ChR, Bratton AC (1951) The anticonvulsant activity of a-phenyl succinimides. J Pharmacol Exp Ther 103: 54–61
Chen G, Weston JK, Bratton AC (1963) Anticonvulsant activity and toxicity of phensuximide, methsuximide and ethosuximide. Epilepsia 4: 66–76
Chiu S, Keifer L, Timberlake JW (1979) Synthesis of imidazolidinediones and oxazolidinediones from cyclization of propargylureas and propargyl carbamates. J Med Chem 22: 746–748
Clemson HC, Magadan EO, Fuller GC, Langner RO (1968) Synthesis of derivatives of N- methyl-2-phenylsuccinimide involving a lithium salt condensation and a novel applica-tion of the Mannich reaction. J Pharm Sci 57: 384–389
Coyne WE, Cusic JW (1968) Anticonvulsant semicarbazides. J Med Chem 11:1158-1160 Crider AM, Kolcynski ThM, Miskell DL (1981) Synthesis and anticonvulsant activity of racemic 2-amino-iV-substituted succinimide derivatives. J Pharm Sci 70: 192–195
Czarnecki R, Sobanski H (1980) Anticonvulsant properties of 5-allyl-(/Miydroxy)propyl-iV-phenylbarbituric acid and the corresponding lactone. Farmaco [Sci] 31: 945–950
Davis JP, Schwade ED (1959) Anticonvulsant effects of 3-allyl-5-isobutyl-2-thiohydantoin (BAX 422Z). Fed Proc 18: 380
Davis MA, Winthrop StO, Thomas RA, Herr F, Charest MP, Gaudry R (1964 a) Anticonvulsants. I.Dibenzo[a,d] cycloheptadiene-5-carboxamide and related compounds. J Med Chem 7: 88–94
Davis MA, Winthrop StO, Thomas RA, Herr F, Charest MP, Gaudry R (1964 b) Anticon-vulsants. II. Spiro compounds. Dibenzo[a,d]cycloheptadiene-5,5′-hydantoins, -5,5′-ox- azolidinediones, and -5,2′-succinimides. J Med Chem 7: 439–445
Desmedt IKC, Niemegeers CJE, Lewi PJ, Janssen PAJ (1976) Antagonism of maximal Metrazol seizures in rats and its relevance to an experimental classification of antiepileptic drugs. Arzneimittelforsch 26: 1592–1603
De Wald HA, Lobbestael S, Butler DE (1977) Pyrazolodiazepines. 2.4-aryl-l,3-dialkyl-6,8- dihydropyrazolo[3,4-e][l,4]diazepine-7-(lH)-ones as antianxiety and anticonvulsant agents. J Med Chem 20: 1562–1569
Dox AW (1925) Tetra-alkyl-succinimides and their pharmacological action. J Am Chem Soc 47: 1471–1477
Everett GM, Richards RK (1952) Pharmacological studies of phenylacetylurea(Phenurone) an anticonvulsant drug. J Pharmacol Exp Ther 106: 303–313
Fabing HD, Gayle RF, Hawkins JR (1947) The treatment of epilepsy with sodium diphenylene hydantoin. Assoc Res Publ Nerv Ment Dis 26: 398–403
Fielding St, Hoffmann I (1979) Pharmacology of anti-anxiety drugs with special reference to clobazam. Br J Clin Pharmacol 7. 7S–15S
Fontanella L, Mariani L, Tarzia G, Corsico N (1976) 3,7-Dihydro-5-phenylpyrrolo[3,4- e][l,4]-diazepine-2(lH)-ones. Synthesis and pharmacological properties. Eur J Med Chem 11: 217–220
Frey HH (1969) Determination of the anticonvulsant potency of unmetabolized trimethadione. Acta Pharmacol Toxicol 27: 295–300
Frey HH, Loscher W (1976) Di-n-propylacetic acid - profile of anticonvulsant activity in mice. Arzneimittelforsch 26: 299–301
Frey HH, Schulz R (1970) Time course of the demethylation of trimethadione. Acta Pharmacol Toxicol 28: 477–483
Funcke ABH, Zandberg P (1970) The anticonvulsive activity in mice of a number of derivatives of 5H-dibenzo[a,d] cycloheptene and its 1- and 3-aza analogues, in comparison with some therapeutically used anticonvulsants. Arzneimittelforsch 20: 1896–1900
Funcke ABH, van Beek MC, van Hell G, Lavy UI, Timmermann H, Zandberg P (1970) Cyheptamide. A pharmacological evaluation. Arch Int Pharmacodyn Ther 187: 174–191
Gagneux AR (1976) The chemistry of carbamazepine. In: Birkmayer W (ed) Epileptic seizures-behaviour-pain. Huber, Bern, p 120
Gal J (1979) Convenient synthesis of TV-alkoxymethylbarbituric acids and iV-alkoxymethylhydantoins. J Pharm Sci 68: 1562–1564
Gallagher BB, Baumel IP, Woodbury SG, Dimicco J A (1975) Clinical evaluation of eterobarb, a new anticonvulsant drug. Neurology 25: 399–404
Ganz AJ, Waser PG, Pfirrmann RW (1978) Die Entwicklung neuer Antiepileptika. V. Pharmakologische Wirkungen einiger Sulfanilamidderivate. Arzneimittelforsch 28: 1331–1334
Gastaut H, Low MD (1979) Antiepileptic properties of clobazam, a 1,5-benzodiazepine, in man. Epilepsia 20: 437–446
Gesler RM, Lints CE, Swinyard EA (1961) Pharmacology of some substituted 2-thiohy-dantoins with particular reference to anticonvulsant properties. Toxicol Appl Pharmacol 3: 107–121
Gluckmann MI (1971) Pharmacology of 7-chloro-5-(o-chlorophenyl)-l,3-dihydro-3-hy- droxy-2H-l,4-benzodiazepine-2-one (lorazepam; WY4036). Arzneimittelforsch 21: 1049–1055
Goldberg MA, Gal J, Cho AK, Jenden DJ (1979) Metabolism of dimethoxymethyl pheno-barbital (eterobarb) in patients with epilepsy. Ann Neurol 5: 121–126
Golik U (1975) The synthesis of some 2,4-benzodiazepine-l-ones, potent CNS agents. J Heterocyclic Chem 12: 903–908
Goodman LS, Toman JEP, Swinyard EA (1946) The anticonvulsant properties of tridione. Am J Med 1: 213–228
Goodman LS, Swinyard EA, Brown WC, Schiffman DO, Grewal MS, Bliss EL (1953) An-ticonvulsant properties of 5-phenyl-5-ethyl-hexahydropyrimidine-4,6-dione ( Myso- line), a new antiepileptic. J Pharmacol Exp Ther 108: 428–436
Goodman LS, Swinyard EA, Brown WC, Schiffman DO (1954) Anticonvulsant properties of 5,5-diphenyl-tetrahydroglyoxaline-4-one. (SKF NO. 2599) J Pharmacol Exp Ther 110: 403–410
Hagen V, Morgenstern E, Gores E, Franke R, Sauer W, Heine G (1980) Quantitative Struktur-Wirkungs-Beziehungen bei antikonvulsiv wirksamen Benzensulfonamiden. Pharmazie 35: 183–185
Hauck FP, Demick J, Fan J (1967) Preparation and anticonvulsant activity of some aryl- dialkylsuccinimides. J Med Chem 10: 611–614
Hauptmann A (1912) Luminal bei Epilepsie. MMW 59: 1907–1909
Hester JB, Rudzik AD, Kamdar BV (1971) 6-Phenyl-4H-s-triazolo[4,3-a][l,4]benzodiaz- epines which have central nervous system depressant activity. J Med Chem 14: 1078–1081
Hester JB, Rudzik AD, von Voigtlander PHF (1980 a) l-(Aminoalkyl)-6-aryl-4H-.s- triazolo[4,3-a][l,4]benzodiazepines with antianxiety and antidepressant activity. J Med Chem 23: 392–402
Hester JB, von Voigtlander Ph, Evenson GN (1980 b) 6-(Substituted-amino)-4H-s- triazolo[4,3-a][l 4]benzodiazepines and 4-(substituted-amino)-6H-,s-triazolo[4,3- a][l,4]benzodiazepines with potential antianxiety activity. J Med Chem 23: 873–877
Johnson DD, Davis HL, Crawford RD (1978) Epileptiform seizures in domestic fowl. VIII. Anticonvulsant activity of primidone and its metabolites, phenobarbital and phenylethylmalonamide. Can J Physiol Pharmacol 56: 630–633
Jones GL, Amato RJ, Wimbish GH, Peyton GA (1981) Comparison of anticonvulsant potencies of cyheptamide, carbamazepine, and phenytoin. J Pharm Sci 70: 618–620
Jucker E, SiieB R (1961) Uber neuartige Spiro-succinimide. Arch Pharm 4: 210 - 220
Kaplan JP, Raizon BM, Desarmenien M, Feltz P, Headley PM, Worms P, Lloyd KG, Bartholini G (1980) New anticonvulsants: Schiff bases of y-aminobutyric acid and y-ami- nobutyramide. J Med Chem 23: 702–704
Knoefel PK, Lehmann G (1942) The anticonvulsant action of diphenylhydantoin and some related compounds. J Pharmacol Exp Ther 76: 194–201
Koella WP, Levin P, Baltzer V (1976) The pharmacology of carbamazepine and some other anti-epileptic drugs. In: Birkmayer W (ed) Epileptic seizures-behaviour-pain. Huber, Bern, p 32
Korosi J, Lang T (1975) Forschungsarbeit auf dem Gebiet der 5H-2,3-benzodiazepine. Ther Hung 23: 141–142
Kornet MJ, Crider AM, Magadan EO (1977 a) Potential long-acting anticonvulsants. 1. Synthesis and activity of succinimides containing an alkylating group at the 2 position. J Med Chem 20: 405–409
Kornet MJ, Crider AM, Magadan EO (1977 b) Potential long-acting anticonvulsants. 2. Synthesis and activity of succinimides containing an alkylating group on nitrogen or at the 3 position. J Med Chem 20: 1210–1213
Krall RL (1980) Structure-activity relationships. Quantitative structure-activity relationship studies of anticonvulsant drugs. In: Glaser GH, Penry JK, Woodbury DM (eds) Antiepileptic drugs: mechanisms of action. Raven, New York, p 233
Krall RL, Penry JK, Kupferberg HJ, Swinyard EA ( 1978 a) Antiepileptic drug development. I. History and a program for progress. Epilepsia 19: 393–408
Krall RL, Penry JK, White BG, Kupferberg HJ, Swinyard EA ( 1978 b) Antiepileptic drug development. II. Anticonvulsant drug screening. Epilepsia 19: 409–428
Kuch H (1979) Clobazam: chemical aspects of the 1,4- and 1,5-benzodiazepines. Br J Clin Pharmacol 7: 17S–21S
Lange J, Rump S, Galecka E, Ilczuk I, Lechowska-Postek M, Rabsztyn T, Szymanska T, Walczyna K (1977 a) Synthesis and properties of new cyclic derivatives of succinic acid with anticonvulsant activity. Pharmazie 32: 82–84
Lange J, Rump S, Ilczuk I, Lapszewicz J, Rabsztyn T, Walczyna K (1977 b) Synthesis and properties of cyclic derivatives of succinic acid with anticonvulsant activity. Pharmazie 32: 579–581
Lange J, Rump S, Ilczuk I, Lapszewicz J, Rabsztyn T, Walczyna K (1979) Synthesis and properties of cyclic derivatives of succinic acid with anticonvulsant activity. Pharmazie 34: 794–795
Lien EJ, Liao RCH, Shinouda HG (1979) Quantitative structure-activity relationships and dipole moments of anticonvulsants and CNS depressants. J Pharm Sci 68: 463–465
Loscher W (1981) Anticonvulsant activity of metabolites of valproic acid. Arch Int Pharmacodyn Ther 249: 158–163
Magadan EO, Becker GW, Diamond L (1973) Anticonvulsant properties of Mannich base derivatives of 2-phenylsuccinimide III. J Pharm Sci 62: 325–327
Marcucci F, Mussini E, Airoldi L, Guaitani A, Garattini S (1972) Brain concentrations of lorazepam and oxazepam at equal degree of anticonvulsant activity. J Pharm Pharmacol 24: 63–64
Masuda Y, Karasawa T, Shiraishi Y, Hori M, Yoshida K, Shimizu M (1980) 3-Sulfamoyl- methyl-l,2-benzisoxazole, a new type of anticonvulsant drug. Arzneimittelforsch 30: 477–483
Mehta NB, Risinger Diuguid ChA, Soroko FE (1981) Potential anticonvulsants. 1,5-benzylhydantoins. J Med Chem 24: 465–468
Mercier J (1973) Chemical compounds possessing anticonvulsant activity. Structure-activity relationships of the antiepileptics. In: Radouco-Thomas C (ed) International encyclopedia of pharmacology and therapeutics, section 19. Anticonvulsant drugs 1. Per- gamon, Oxford, p 203
Merritt HH, Putnam TJ (1945) Experimental determination of anticonvulsive activity of chemical compounds. Epilepsia 3: 51–75 (sec series, Banta, Menasha, Wisconsin)
Meunier H, Carraz G, Meunier Y, Eymard P, Aimard M (1963) Proprietes pharmacody-namiques de l’acide w-dipropylacetique. Therapie 18: 435–438
Miller CA, Long LM (1951) Anticonvulsants. I. An investigation of N-R-a-R1-a-phenyl- succinimides. J Am Chem Soc 73: 4895–4898
Miller CA, Lono LM (1953a) Anticonvulsants. III. A study of N,α,β-alkylsuccinimides. J Am Chem Soc 75: 373–375
Miller CA, Long LM ( 1953 b) Anticonvulsants. IV. An investigation of a-(substituted phenyl)-succinimides. J Am Chem Soc 75: 6256–6258
Miller CA, Scholl HI, Long LM (1951) Anticonvulsants. II. A study of N-R-a,β-substituted succinimides. J Am Chem Soc 73: 5608–5610
Millichap JG, Ortiz WR (1967) Albutoin, a new thiohydantoin derivative for grand mal epilepsies. Comparison with diphenylhydantoin in a double-blind, controlled study. Neurology 17: 162–165
Millichap JG (1972) Mephenytoin, Ethotoin, and albutoin. In: Penry JK, Schmidt RP, Woodbury DM (eds) Antiepileptic drug. Raven, New York, p 275
Müller WE (1981) The benzodiazepine receptor. Pharmacology 22: 153–161
Nakamura K, O’Hashi K, Nakatsuji K, Hiroka T, Fujimoto K, Ose S (1965) The anticonvulsant activity of 3-ethoxycarbonyl-5,5-diphenylhydantoin (P-6127) in animals. Arch Int Pharmacodyn Ther 156: 261–270
Nakamura K, Masuda Y, Nakatsuji K, Hiroka T (1966) Comparative studies on the distribution and metabolic fate of diphenylhydantoin and 3-ethoxycarbonyldiphenylhy- dantoin (P-6127) after chronic administrations to dogs and cats. Arch Exp Pathol Pharmacol 254: 406–417
Nakamura K, Murai K, Nakatsuji K, Kobayashi M, Masuda Y, Kadokawa T, Soji Y, Nakamura H, Hiroka T, Senda H (1968) Neuropharmacological and toxicological studies on a new anti-epileptic, Af-a-ethyl-phenylacetyl-W-acetyl urea in experimental animals. Arzneimittelforsch 5: 524–529
Nardi D, Tajana A, Leonardi A, Penini R, Portioli F, Magistretti MJ, Subissi A (1981) Synthesis and anticonvulsant activity of N-(benzoylalkyl)imidazoles and Af-(a)-phenyl-co- hydroxyalkyl)imidazoles. J Med Chem 24: 727–731
Nelson WL, Kwon YG, Marshall GL, Hoover JL, Pfeffer GT (1979) Fluorinated phenytoin anticonvulsant analogs. J Pharm Sci 68: 115–117
Oldfield W, Cashin CH (1965) The chemistry and pharmacology of a series of cycloalkanespiro-5′-hydantoins. J Med Chem 8: 239–249
Perlstein MA, Andelman MB (1946) Tridione, its use in convulsive and related disorders. J Pediatr 29: 20–40
Petocz L, Kosoczky I (1975) Die wichtigeren pharmakologischen Parameter von Grandaxin (Toflzopam; egyt-341) Ther Hung 23: 143–147
Raines A, Niner JM, Pace DG (1973) A comparison of the anticonvulsant, neurotoxic and lethal effects of diphenylbarbituric acid, phenobarbital and diphenylhydantoin in the mouse. J Pharmacol Exp Ther 186: 315–322
Raines A, Baumel I, Gallagher BB, Niner JM (1975) The effects of 5,5-diphenylbarbituric acid on experimental seizures in rats: correlation between plasma and brain concentrations and anticonvulsant activity. Epilepsia 16: 575–581
Raines A, Blake GJ, Richardson B, Gilbert MB (1979) Differential selectivity of several barbiturates on experimental seizures and neurotoxicity in the mouse. Epilepsia 20: 105–113
Randall LO, Schallek W, Scheckel C, Banziger R, Moe RA (1968) Zur Pharmakologie des neuen Psychopharmakons 7-chlor-2,3-dihydro-l -methyl- 5-phenyl-l H-\,4-benzodiaze- pin (Ro 5-4556). Arzneimittelforsch 18: 1542–1545
Randall LO, Kappell B (1973) Pharmacological activity of some benzodiazepines and their metabolites. In: Garattini S, Mussini E, Randall LO (eds) The benzodiazepines. Raven, New York, p 27
Rossi S, PirolaO, Maggi R (1969) Sintesidi l,2,4,5-tetraidro-2,4-dicheto-3/7-l,5-benzodiazepine. Chim Ind (Milan) 51: 479–483
Rump S, Ilczuk I, Rabsztyn T, Walczyna K (1981) Pharmacological properties of N-ami- nodiphenylhydantoin, a new hydantoin derivative with anticonvulsant activity. Phar- mazie 36: 780–781
Sadagopa Ramanujam VM, Trieff NM (1978) Structure activity relation for some 1,4-ben- zodiazepinones: correlation between rate constants for reduction by sodium borohydride and antileptazol ED50. J Pharm Pharmacol 30: 542–546
Samour CM, Reinhard JF, Vida JA (1971) Anticonvulsants. 1. Alkoxamethyl derivatives of barbiturates and diphenylhydantoin. J Med Chem 14: 187–189
Samson FE, Dahl N, Dahl DR (1956) A study on the narcotic action of the short chain fatty acids. J Clin Invest 35: 1291–1298
Schafer H (1969) 5,5-Diphenylhydantoin-Aft-carbonsaureester. German Patent 1966802 (Desitin-Werk Carl Kinke GmbH) Schafer H, Liihrs R (1978) Metabolite pattern of valproic acid. Part I: gas chromatographic determination of the valproic acid metabolite artifacts, heptanone-3, 4- and 5- hydroxyvalproic acid lactone. Arzneimittelforsch 28: 657–662
Schafer H, Lührs R, Reith H (1980) Chemistry, pharmacokinetics, and biological activity of some metabolites of valproic acid. In: Johannessen SI, Morselli PL, Pippenger CR, Richens A, Schmidt D, Meinardi H (eds) Antiepileptic therapy: advances in drug monitoring. Raven, New York, p 103
Schlogl K, Wessely F, Kraupp O, Stormann H (1961) Synthese und Pharmakologie einiger 3,5-di- und trisubstituierter Hydantoine. J Med Pharm Chem 4: 231–258
Scoular IT, Nicholls PJ, Smith HJ (1976) Anticonvulsant properties of some new 3-phenyl-2,5-pyrrolidinediones. Eur J Med Chem 11: 91–93
Shaffer JW, Steinberg E, Krimsley V, Winstead MB (1968) Substitution in the hydantoin ring. VII. N-3-propionic acid and its ethyl ester and N-3-(2-cyanoethyl) derivatives. J Med Chem 11: 462–466
Sohn YJ, Levitt B, Raines A (1970) Anticonvulsant properties of diphenylthiohydantoin. Arch Int Pharmacodyn Ther 188: 284–289
Soroko FE, Grivsky E, Maxwell RA (1981) Cinromide (3-bromo-iV-ethylcinnanamide), a novel anticonvulsant agent. J Pharm Pharmacol 33: 741–743
Spielman MA, Geiszler AO, Close WJ (1948) Anticonvulsant drugs. II. Some acylureas. J Am Chem Soc 70: 4189–4191
Sternbach LH (1973) Chemistry of 1,4-benzodiazepines and some aspects of the structure- activity relationship. In: Garattini S, Mussini E, Randall LO (eds) The benzodiazepines. Raven, New York, p 1
Sternbach LH (1980) The benzodiazepine story. In: Priest RG, Vianna Filho U, Amrein R, Skreta M (eds) Benzodiazepines today and tomorrow. MTP, Falcon House, England, p 5
Sternbach LH, Randall LO, Banziger R, Lehr H (1968) Structure-activity relationships in the 1,4-benzodiazepine series. In: Burger A (ed) Drugs affecting the central nervous system. Dekker, New York, p 237
Sternbach LH, Sancilio FD, Blount JF (1974) Quinazolines and 1,4-benzodiazepines. 64. Comparison of the stereochemistry of diazepam with that of close analogs with marginal biological activity. J Med Chem 17: 374–377
Swinyard EA, Castellion AW (1966) Anticonvulsant properties of some benzodiazepines. J Pharmacol Exp Ther 151: 369–375
Swinyard EA, Toman JEP (1950) A comparison of the anticonvulsant actions of some phe- nylhydantoins and their corresponding phenylacetylureas. J Pharmacol Exp Ther 100: 151–157
Swinyard EA, Brown WC, Goodman LS (1952) Comparative assays of antiepileptic drugs in mice and rats. J Pharmacol Exp Ther 106: 319–330
Taillandier G, Benoit-Guyod JL, Boucherle A, Broil M, Eymard P (1975) Recherches dans la serie dipropylacetique. XII. Acides et alcools aliphatiques ramifies anticonvulsivants. Eur J Med Chem 10: 453–462
Taillandier G, Benoit-Guyod JL, Laruelle C, Boucherle A (1977) Investigation in the di- propylacetic acid series, C8 and C9 branched chain ethylenic acids and amides. Arch Pharm 310: 394–403
Tchicaloff M, Mitroi G (1975) Priifung des neuen Antiepileptikums G385. Z EEG EMG 6: 133–136
Theobald W, Kunz HA (1963) Zur Pharmakologie des Antiepileptikums 5-carbamyl-5H- dibenzo[b,f]azepin. Arzneimittelforsch 13: 122–125
Tinney FJ, Sanchez JP, Nogas JA (1974) Synthesis and pharmacological evaluation of 2,3- dihydro-l/Rhieno[2,3-e][l,4]diazepines. J Med Chem 17: 624–630
Toman JEP, Swinyard EA, Goodman LS (1946) Properties of maximal seizures, and their alteration by anticonvulsant drugs and other agents. J Neurophysiol 9: 231–239
Traversa U, De Angelis L, Vertua R (1977) On the hypnogenic and anticonvulsant activities of demethyldiazepam and chlordemethyldiazepam: time-effect relations. J Pharm Pharmacol 29: 504–506
Uno H, Kurokawa M, Masuda Y, Nishimura H (1979) Studies on 3-substituted 1,2-ben- zisoxazole derivatives. 6.Syntheses of 3-(sulfamoylmethyl)-l,2-benzisoxazole derivatives and their anticonvulsant activities. J Med Chem 22: 180–183
Vida JA (1977) Anticonvulsants. Academic, New York
Vida JA, Gerry EH (1977) Cyclic ureides. In: Vida J A (ed) Anticonvulsants. Academic, New York, p 151
Vida JA, Wilber WR, Reinhard JF (1971) Anticonvulsants. 2. Acyloxymethyl and halo- methyl derivatives of barbituric acid and diphenylhydantoin. J Med Chem 14: 190–193
Vida J A, Hooker ML, Reinhard JF ( 1973 a) Anticonvulsants. 3. Phenobarbital and mephobarbital derivatives. J Med Chem 16: 602–605
Vida JA, Hooker ML, Samour CM ( 1973 b) Anticonvulsants. 4. Metharbital and phenobarbital derivatives. J Med Chem 16: 1378–1381
Vida JA, O’Dea MH, Samour CM, Reinhard JF (1975) Anticonvulsants. 5. Derivatives of 242 5-ethyl-5-phenylhydantoin and 5,5-diphenylhydantoin. J Med Chem 18: 383–385
Walker KAM, Wallach MB, Hirschfeld DR (1981) l-(Naphthylalkyl)-l//-imidazole derivatives, a new class of anticonvulsant agents. J Med Chem 24: 67–74
Waser PG, Ganz AJ, Pfirrmann RW ( 1977 a) Die Entwicklung neuer Antiepileptika. I. An- tikonvulsive Wirkung von Af-(p-Sulfamoylphenyl)-succinimid-Derivaten. Arzneimit- telforsch 27: 1942–1953
Waser PG, Ganz A J, Pfirrmann RW ( 1977 b) Die Entwicklung neuer Antiepileptika. II. Antikonvulsive Wirkung einiger Hydantoin-Derivate. Arzneimittelforsch 27: 2125–2128
Waser PG, Ganz AJ, Pfirrmann RW (1977 c) Die Entwicklung neuer Antiepileptika. III. Antikonvulsive Wirkung einiger l-(/?-Sulfamoylphenyl)-imidazolidinon-5-Deriva- te. Arzneimittelforsch 27: 2336–2341
Waser PG, Ganz AJ, Pfirrmann RW (1978) Die Entwicklung neuer Antiepileptika. IV. An-tikonvulsive Wirkung einiger l-(N-Sulfamoyl-phenyl)-pyrrolidin-2-on-Derivate. Arz-neimittelforsch 28: 952–956
Weese H (1932) Pharmakologie des Prominal. Dtsch Med Wochenschr 58:696 Winstead MB, Hamel CR (1965) Substitution in the hydantoin ring. II. N-3-acetic acid derivatives. J Med Chem 8: 120–123
Winstead MB, Barr DE, Hamel CR, Renn DJ, Parker HI, Neumann RM (1965) Substitution in the hydantoin ring. I. N-3-aminomethyl derivatives. J Med Chem 8: 117–120
Witiak DT, Vishnuvajjala BR, Cook WL, Minatelli JA, Gupta TK, Gerald MC (1977) 3,4- Methylenedioxyphenyl-, isopropylidenedioxyphenyl-, and benzyl-substituted chiral 2- aminosuccinimides and 3-aminopyrrolidines. Stereoselective investigations of potential anti-parkinsonian, antipsychotic, and anticonvulsant activities. J Med Chem 20: 801–805
Zimmermann FT, Burgemeister BB (1958) A new drug for petit mal epilepsy. Neurology 8: 769–775
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schäfer, H. (1985). Chemical Constitution and Pharmacological Effect. In: Frey, HH., Janz, D. (eds) Antiepileptic Drugs. Handbook of Experimental Pharmacology, vol 74. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69518-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-69518-6_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69520-9
Online ISBN: 978-3-642-69518-6
eBook Packages: Springer Book Archive